Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis
Author(s) -
Guocai Lv
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i22.3481
Subject(s) - adefovir , medicine , gastroenterology , lamivudine , cirrhosis , seroconversion , hepatitis b virus , hepatitis b , combination therapy , immunology , virus
To investigate the efficacy and safety of combined de novo lamivudine (LAM) and adefovir dipivoxil (ADV) therapy in hepatitis B virus (HBV)-related decompensated liver cirrhosis patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom